Abstract
Serum concentrations and urinary excretion of ciprofloxacin were studied in female and male volunteers following a single oral administration of 100 mg, 250 mg, 500 mg or 1000 mg. Serum and urine concentrations increased proportionally to the increasing dose administered but independently of sex. Twenty-five percent of the administered dose was excreted in the urine as unmetabolized ciprofloxacin within the first 24 hours after oral administration. Renal clearance averaged 5 ml/min × kg.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bauernfeind, A., Petcrmüller, C.: In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid. European Journal of Clinical Microbiology 1983, 2: 111–115.
Wise, R., Andrews, J. M., Edwards, L. J.: In vitro activity of Bay o 9867, a new quinoline derivative compared with those of other antimicrobial agents. Antimicrobial Agents and Chemotherapy 1983, 23: 559–564.
Zeiler, H. J., Grohe, K.: In vitro and in vivo activity of ciprofloxacin. European Journal of Clinical Microbiology 1984, 3: 339–343.
Crump, B., Wise, R., Dent, J.: Pharmacokinetics and tissue penetration of ciprofloxacin. Antimicrobial Agents and Chemotherapy 1983, 24: 784–786.
Wingender, W., Graefe, K. H., Gau, W., Förster, D., Beermann, D., Schacht, P.: Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers. European Journal of Clinical Microbiology 1984, 3: 355–359.
v. Hattingberg, H. M., Brockmeier, D.: The pharmacokinetic basis of optimal antibiotic dosage. Infection 1980, 8, Supplement 1: 21–24.
Yamaoto, K., Nakagawa, T., Uno, T.: Statistical moments in pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics 1978, 6: 547–558.
Swanson, B. N., Bopparia, K. K., Vlasses, P. H., Rotmensch, H. H., Ferguson, R. K.: Norfloxacin disposition after sequentially increasing oral doses. Antimicrobial Agents and Chemotherapy 1983, 23: 284–288.
Shah, P. M., Strehl, R., Posselt, H. G., Bender, S. W.: Ciprofloxacin bei Mucoviscidose-Cystischer Fibrose, eine pharmacokinetische Untersuchung. Fortschritte in der antineoplastischen, antimikrobiellen Chemotherapie. Futuramed-Verlag, Munich (in press).
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1986 Springer Fachmedien Wiesbaden
About this chapter
Cite this chapter
Höffler, D., Dalhoff, A., Gau, W., Beermann, D., Michl, A. (1986). Dose- and Sex-Independent Disposition of Ciprofloxacin. In: Neu, H.C., Reeves, D.S. (eds) Ciprofloxacin. Current Topics in Infectious Diseases and Clinical Microbiology, vol 1. Vieweg+Teubner Verlag, Wiesbaden. https://doi.org/10.1007/978-3-663-01930-5_21
Download citation
DOI: https://doi.org/10.1007/978-3-663-01930-5_21
Publisher Name: Vieweg+Teubner Verlag, Wiesbaden
Print ISBN: 978-3-663-01931-2
Online ISBN: 978-3-663-01930-5
eBook Packages: Springer Book Archive